Work

Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease

Year: 2022

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2022.08.036

Authors: Daniel Q. Huang, Suzanne R. Sharpton, Maral Amangurbanova, Nobuharu Tamaki, Claude B. Sirlin, Rohit Loomba, Ricki Bettencourt, Egbert Madamba, Jinho Jung, Harris Siddiqi, Lisa Richards, Mark A. Valasek, Cynthia Behling

Institutions: National University of Singapore, University of California San Diego, National University Health System, Musashino Red Cross Hospital

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G1316440902, G1370780335, G1494183008, G1622551803, Novel IL-23 inhibitor for the treatment of alcohol associated liver disease, G745677937, G7501542120, San Diego Digestive Diseases Research Center, San Diego Cirrhosis Clinical Research Network

OpenAlex ID: W4294723985

FWCI: 5.95

Cites: 15

Cited by: 49

Related to: 10